Beta Bionics Statistics Share Statistics Beta Bionics has 43.47M
shares outstanding. The number of shares has increased by null%
in one year.
Shares Outstanding 43.47M Shares Change (YoY) n/a Shares Change (QoQ) n/a Owned by Institutions (%) 99.99% Shares Floating n/a Failed to Deliver (FTD) Shares 2,298 FTD / Avg. Volume 0.42%
Short Selling Information The latest short interest is 4.8M, so 11.08% of the outstanding
shares have been sold short.
Short Interest 4.8M Short % of Shares Out 11.08% Short % of Float 12.51% Short Ratio (days to cover) 11.48
Valuation Ratios The PE ratio is -2.75 and the forward
PE ratio is -8.01.
Beta Bionics's PEG ratio is
-0.79.
PE Ratio -2.75 Forward PE -8.01 PS Ratio 2.31 Forward PS 5.1 PB Ratio 1.98 P/FCF Ratio -2.91 PEG Ratio -0.79
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Beta Bionics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 6.29,
with a Debt / Equity ratio of 0.1.
Current Ratio 6.29 Quick Ratio 5.66 Debt / Equity 0.1 Debt / EBITDA -0.16 Debt / FCF -0.14 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $185.01K Profits Per Employee $-155.56K Employee Count 352 Asset Turnover 0.44 Inventory Turnover 2.19
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by null% in the
last 52 weeks. The beta is 5.82, so Beta Bionics's
price volatility has been higher than the market average.
Beta 5.82 52-Week Price Change n/a 50-Day Moving Average 15.8 200-Day Moving Average n/a Relative Strength Index (RSI) 47.46 Average Volume (20 Days) 548,974
Income Statement In the last 12 months, Beta Bionics had revenue of 65.12M
and earned -54.76M
in profits. Earnings per share was -8.6.
Revenue 65.12M Gross Profit 35.89M Operating Income -45.25M Net Income -54.76M EBITDA -44.1M EBIT -45.25M Earnings Per Share (EPS) -8.6
Full Income Statement Balance Sheet The company has 30.43M in cash and 7.25M in
debt, giving a net cash position of 23.18M.
Cash & Cash Equivalents 30.43M Total Debt 7.25M Net Cash 23.18M Retained Earnings -296.74M Total Assets 329.97M Working Capital 266.59M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -48.27M
and capital expenditures -3.4M, giving a free cash flow of -51.67M.
Operating Cash Flow -48.27M Capital Expenditures -3.4M Free Cash Flow -51.67M FCF Per Share -8.12
Full Cash Flow Statement Margins Gross margin is 55.11%, with operating and profit margins of -69.48% and -84.08%.
Gross Margin 55.11% Operating Margin -69.48% Pretax Margin -84.08% Profit Margin -84.08% EBITDA Margin -67.72% EBIT Margin -69.48% FCF Margin -79.34%
